Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Glowing footsteps may improve gait in kids with cerebral palsy

NCT ID NCT07289347

Symptom relief Sponsor: Amira saad mohamed Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether walking on a path with lights that show where to step can improve how children with spastic diplegia (a type of cerebral palsy) walk. Thirty children aged 5 to 8 with mild spasticity will walk on the light pathway, and researchers will measure changes in step length, width, spasticity, and motor function. The goal is to see if this simple, fun approach can help them move more easily.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Sep 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 8 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age will range between5 and 8 years old. * They had Grade 1 and 1+ hypertonia according to Modified Ashworth Scale (Bohannon and Smith, 1987) * Motor Classification System, they were at level I and II (GMFCS) * They will capable of following commands and comprehend them. * They will exhibit defective gait kinematics, which can be determined through gait kinematics evaluation. * All patients who will be enrolled to the study will have their informed consent. Exclusion Criteria: * Epilepsy history. * Taking any anti spastic drugs. * Both lower limbs had permanent deformity. * Surgical intervention history. * Have visual or auditory defects. * Chest infections or unstable cardiac status. * Infective skin conditions. * Markedly high or low blood pressure. * Individuals with cardiopulmonary conditions. * Individuals with any pelvic disease. * Individuals undergoing radiation therapy or chemotherapy. * Hepatic or pancreatic diseases.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spastic diplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy spastic diplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spastic diplegia

Contacts and locations

Locations

  • Cairo University

    Giza, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.